These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 19919843)

  • 1. Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel.
    Ma TK; Lam YY; Tan VP; Kiernan TJ; Yan BP
    Pharmacol Ther; 2010 Feb; 125(2):249-59. PubMed ID: 19919843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug interaction between clopidogrel and proton pump inhibitors.
    Khalique SC; Cheng-Lai A
    Cardiol Rev; 2009; 17(4):198-200. PubMed ID: 19525682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonresponders to clopidogrel: pharmacokinetics and interactions involved.
    Giorgi MA; Di Girolamo G; González CD
    Expert Opin Pharmacother; 2010 Oct; 11(14):2391-403. PubMed ID: 20828266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
    Laine L; Hennekens C
    Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel-drug interactions.
    Bates ER; Lau WC; Angiolillo DJ
    J Am Coll Cardiol; 2011 Mar; 57(11):1251-63. PubMed ID: 21392639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interaction between clopidogrel and proton pump inhibitors.
    Liu TJ; Jackevicius CA
    Pharmacotherapy; 2010 Mar; 30(3):275-89. PubMed ID: 20180611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.
    Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):532-9. PubMed ID: 20729752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors in patients treated with aspirin and clopidogrel after acute coronary syndrome.
    Gaspar A; Ribeiro S; Nabais S; Rocha S; Azevedo P; Pereira MA; Brandāo A; Salgado A; Correia A
    Rev Port Cardiol; 2010 Oct; 29(10):1511-20. PubMed ID: 21265493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
    Lettino M
    Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel resistance: identifying and overcoming a barrier to effective antiplatelet treatment.
    Uchiyama S
    Cardiovasc Ther; 2011 Dec; 29(6):e100-11. PubMed ID: 21883990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
    Luinstra M; Naunton M; Peterson GM; Bereznicki L
    J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
    Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
    Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in clopidogrel pharmacology and their relation to clinical outcomes.
    Gurbel PA; Antonino MJ; Tantry US
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):989-1004. PubMed ID: 19575629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy.
    Zuern CS; Geisler T; Lutilsky N; Winter S; Schwab M; Gawaz M
    Thromb Res; 2010 Feb; 125(2):e51-4. PubMed ID: 19781742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
    Gilard M; Arnaud B; Cornily JC; Le Gal G; Lacut K; Le Calvez G; Mansourati J; Mottier D; Abgrall JF; Boschat J
    J Am Coll Cardiol; 2008 Jan; 51(3):256-60. PubMed ID: 18206732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of clopidogrel and statins: a hypothetical interaction or therapeutic dilemma?
    Tafreshi MJ; Zagnoni LG; Gentry EJ
    Pharmacotherapy; 2006 Mar; 26(3):388-94. PubMed ID: 16503718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of metabolic activation pathways: the example of clopidogrel and prasugrel.
    Petersen KU
    Arzneimittelforschung; 2009; 59(5):213-27. PubMed ID: 19537521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: proton pump inhibitors with clopidogrel--evidence for and against a clinically-important interaction.
    Disney BR; Watson RD; Blann AD; Lip GY; Anderson MR
    Aliment Pharmacol Ther; 2011 Apr; 33(7):758-67. PubMed ID: 21303400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
    Wenaweser P; Windecker S; Billinger M; Cook S; Togni M; Meier B; Haeberli A; Hess OM
    Am J Cardiol; 2007 Feb; 99(3):353-6. PubMed ID: 17261397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An insight into the interaction between clopidogrel and proton pump inhibitors.
    Shah BS; Parmar SA; Mahajan S; Mehta AA
    Curr Drug Metab; 2012 Feb; 13(2):225-35. PubMed ID: 22300021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.